
The WFH Guidelines for the Management of Hemophilia: AAV Gene Therapy
The WFH Guidelines for the Management of Hemophilia: AAV Gene Therapy provide the first comprehensive, evidence-based recommendations to support the
Year: 2020
Language: English
Author(s): World Federation of Hemophilia
Listen as Glenn Pierce, MD, PhD (WFH VP Medical), Flora Peyvandi, MD, PhD, Magdy El Ekiaby, MD, Cedric Hermans, MD, PhD, and Radoslaw Kaczmarek, PhD, provide the global bleeding disorders community with up-to-date information on COVID-19. This 1-hour webinar, presented on April 9, 2020, also addressed participants’ questions and concerns.
To download a pdf of the slides of the webinar, click the icon below.
This webinar has been transcribed. Please click on the icon below to access a summary of the transcript.

The WFH Guidelines for the Management of Hemophilia: AAV Gene Therapy provide the first comprehensive, evidence-based recommendations to support the

Raising funds requires careful research and detailed planning, as well as creativity and good business practices. The second edition of

The 2026 version is available in: SpanishThe 2018 version booklet is available in: English, Arabic, French, Russian, Spanish, Simplified Chinese Using

The 3rd edition has also been translated into the following languages, with permission from the WFH, by NMOs/Other Organizations: Georgian,

In celebration of International Women’s Day, the World Federation of Hemophilia (WFH) hosted a webinar focused on postpartum hemorrhage and

A 3ª edição do Manual de Laboratório da WFH é o guia definitivo para o diagnóstico preciso da hemofilia e